Legal Entity
Insights
OASIS PTE. LTD.
Last Updated: 17 Jun 2026
One of the most respected, member-driven standards bodies in the world, OASIS offers projects—including open source projects—a path to standardization and de jure approval for reference in international policy and procurement.
OASIS has a broad technical agenda encompassing artificial intelligence, cybersecurity, privacy, supply chain, blockchain, cryptography, cloud computing, IoT, emergency management, and much more. In fact, any initiative for developing code, APIs, specifications, or reference implementations can find a home at OASIS.
Each project operates independently under industry-approved process and IPR policies.
Some of the most widely adopted OASIS Standards include AMQP, CAP, CMIS, CSAF, DITA, DocBook, KMIP, MQTT, OpenC2, OpenDocument, PKCS, SAML, STIX, TAXII, TOSCA, UBL, and XLIFF. Many of these have gone on to be published as ISO, IEC, or ITU standards. New work is encouraged, and all are welcome to participate.
OASIS members can be found in 100+ countries on virtually every continent. Major multinational companies, SMEs, government agencies, universities, research institutions, consulting groups, and individuals are represented.
Join OASIS and become part of this global community.
Country of registration | Singapore |
Registration number | 200302011E |
Local SIC | |
Incorporation date | 6 Mar 2003 |
Company age | 23 years 3 months |
Official entity type | Exempt Private Limited Company |
No. of officers | 8 |
Contact
Address:
66 BAYSHORE ROAD, #13-06, BAYSHORE PARK, Singapore 469985
Access Key Decision Makers
This is the legal entity page of OASIS PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (2)
- OASISView MoreUnited States of AmericaOne of the most respected, member-driven standards bodies in the world, OASIS offers projects—including open source projects—a path to standardization and de jure approval for reference in international policy and procurement. OASIS has a broad technical agenda encompassing artificial intelligence, cybersecurity, privacy, supply chain, blockchain, cryptography, cloud computing, IoT, emergency management, and much more. In fact, any initiative for developing code, APIs, specifications, or reference implementations can find a home at OASIS. Each project operates independently under industry-approved process and IPR policies. Some of the most widely adopted OASIS Standards include AMQP, CAP, CMIS, CSAF, DITA, DocBook, KMIP, MQTT, OpenC2, OpenDocument, PKCS, SAML, STIX, TAXII, TOSCA, UBL, and XLIFF. Many of these have gone on to be published as ISO, IEC, or ITU standards. New work is encouraged, and all are welcome to participate. OASIS members can be found in 100+ countries on virtually every continent. Major multinational companies, SMEs, government agencies, universities, research institutions, consulting groups, and individuals are represented. Join OASIS and become part of this global community.
- GENE OASISView MoreSingaporeGene Oasis is a Singapore-registered business group that develops and manufactures natural bioactive ingredients, innovative products and efficient delivery systems built on a strong portfolio of proprietary technologies and intellectual property. Its GO BioEnterprise commercial arm extracts next-generation peptide compositions primarily from edible bird nests and operates two business pillars: a sustainable food raw materials supply platform based on proprietary extraction technologies, and the development and commercialisation of novel milk-based peptide formulations. Gene Oasis combines a dedicated scientific advisory board, state-of-the-art manufacturing and an in-house factory to drive discovery, development and commercialisation of bio-pharmaceutical and nutraceutical products. The company collaborates with prestigious research institutions to expand and commercialise its IP and focuses research efforts across induced pluripotent stem cells, telomere and mitochondria therapies, immuno- and ER therapies, mesenchymal stem cells, metabolomics, precision diagnostics, microRNAs, glyco-therapeutics, exosomes and neuromedicine to achieve cellular regeneration, health and vitality.
This is the legal entity page of OASIS PTE. LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Auditor | C W THUM & CO |
Revenue | 1 - 10m |
Share Capital - Ordinary shares | SGD 1,000,000 |
Last updated: 17 Jun 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of OASIS PTE. LTD.?
- Where is OASIS PTE. LTD.'s headquarter?
- What is OASIS PTE. LTD.'s contact number?
- What OASIS PTE. LTD.'s spending power?
- Does OASIS PTE. LTD. have a presence in the domain it operates in?